AN OPEN-LABEL, RANDOMIZED PROSPECTIVE STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF CAMPATH-1H AS AN INDUCTION AGENT IN COMBINATION WITH LOW DOSE-TACROLIMUS, LOW DOSE –MMF AND REDUCED STEROID THERAPY COMPARED TO ATG-INDUCTION IN COMBINATION WITH TACROLIMUS, MYCOPHENOLATE MOFETIL AND STEROIDS THERAPYIN DE NOVO LUNG TRANSPLANTED PATIENTS - LUCIA
- Registration Number
- EUCTR2007-001815-51-AT
- Lead Sponsor
- General Hospital Vienna, Dept Cardio-thoracic surgeray
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: ;Secondary Objective: ;Primary end point(s):
- Secondary Outcome Measures
Name Time Method